Latest
Tirzepatide
$40.00
A dual GIP/GLP-1 receptor agonist used clinically for type 2 diabetes and weight management (sold as Mounjaro/Zepbound).
$40.00
A dual GIP/GLP-1 receptor agonist used clinically for type 2 diabetes and weight management (sold as Mounjaro/Zepbound).
Looks like you haven't made a choice yet.
Reviews
There are no reviews yet.